A more effective therapy has emerged for preventing hormone-sensitive breast cancers returning in younger women. A global study, published overnight in the New England Journal of Medicine, has shown that…
- Professor of Oncology, Head of the RMH Familial Cancer Centre and Joint Head, Breast Cancer Laboratory, WEHI (Walter and Eliza Hall Institute of Medical Research)
Use of the anti-cancer drug Tamoxifen is associated with a dramatically reduced risk of developing a second breast tumour among women with a high risk gene mutation who have experienced breast cancer already…
Combining a special anti-cancer compound with conventional cancer-fighting drugs can slow down the growth of the most common form of breast cancer and can even cause some tumours to disappear completely…
Actress Angelina Jolie’s op-ed in the New York Times explained that she opted to have a double mastectomy because she carries the hereditary BRCA1 gene, which she says increases her risk of breast cancer…
Contact Geoff for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- Joined
